offline
Merck's stock gains after profit and sales beat, but outlook is downbeat
...
Net income rose to $3.22 billion, or $1.26 a share, from $3.18 billion, or $1.12 a share, in the year-ago period. Excluding non-recurring items, adjusted earnings per share rose to $1.50 from $1.22, above the FactSet consensus of $1.34. Sales increased 11% to $12.06 billion to beat the FactSet consensus of $11.48 billion.
...
https://www.marketwatch.com/story/mercks...eid=yhoof2
![[Bild: MRKc1dl1026.png]](https://finviz.com/publish/042920/MRKc1dl1026.png)
...
Net income rose to $3.22 billion, or $1.26 a share, from $3.18 billion, or $1.12 a share, in the year-ago period. Excluding non-recurring items, adjusted earnings per share rose to $1.50 from $1.22, above the FactSet consensus of $1.34. Sales increased 11% to $12.06 billion to beat the FactSet consensus of $11.48 billion.
...
https://www.marketwatch.com/story/mercks...eid=yhoof2
__________________
